This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schrappe M, Camitta B, Pui CH . Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia 2000; 14: 2193–2194.
Pui CH, Evans WE, Gilbert JR . Meeting report: International childhood ALL workshop. Memphis, TN, 3–4 December 1997. Leukemia 1998; 8: 1313–1318.
Smith M, Arthur D, Camitta B, Carroll AJ, Crist W . Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996; 1: 18–24.
Pui CH, Schrappe M, Camitta B . Normal and malignant hemopoiesis: spotlight on long-term results of pediatric ALL clinical trials from study 12 groups world wide. Leukemia 2000; 14: 2193–2320.
Pui CH, Sallan S, Relling MV, Masera G, Evans WE . Inter-national Childhood Acute Lymphoblastic Leukemia Workshop. Sausalito, CA, 30 November–1 December 2000. Leukemia 2001; 15: 707–715.
Aricò M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000; 342: 998–1006.
Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909–1915.
Chessells JM, Harrision CJ, Watson SL, Vora AJ, Richards SM . Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987–1999. Br J Haematol 2002; 117: 306–314.
Forestier E, Johansson B, Gustafsson G, Borgstrom G, Kerndrup G, Johannsson J et al. Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group. Br J Haematol 2000; 110: 147–153.
Relling MV, Yanishevski Y, Nemec J, Evans WE, Boyett JM, Behm FG et al. Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia. Leukemia 1998; 12: 346–352.
Bo J, Schroder H, Kristinsson J, Madsen B, Szumlanski C, Weinshilboum R et al. Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism. Cancer 1999; 86: 1080–1086.
Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK et al. Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci USA 1998; 95: 13176–13181.
Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM et al. Prevalence of the inactivating 609C–>T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999; 94: 803–807.
Blanco JG, Edick MJ, Schuster JJ, Dervieux T, Amylon MD, Bash RO et al. Genetic polymorphisms in NQO1 and CYP3A4 in children with treatment-related acute myeloid malignancies. Blood 2001; 98: 323a (abstract 1365).
Blanco JG, Dervieux T, Edick MJ, Mehta PK, Rubnitz JE, Shurtleff S et al. Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2001; 98: 10338–10343.
van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L et al. Prognostic value of minimal residual disease in acute lymphoblastic leukemia in childhood. Lancet 1998; 352: 1731–1738.
Niini T, Kanerva J, Vettenranta K, Saarinen-Pihkala UM, Knuutila S . AML1 gene amplification a novel finding in childhood acute lymphoblastic leukemia. Haematologica 2000; 85: 362–366.
Busson-Le Coniat M, Nguyen Khac F, Daniel MT, Bernard OA, Berger R . Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemia. Genes Chromosomes Cancer 2001; 32: 244–249.
Dal Cin P, Atkins L, Ford C, Ariyanayagam S, Armstrong SA, George R et al. Amplification of AML1 in childhood acute lymphoblastic leukemias. Genes Chromosomes Cancer 2001; 30: 407–409.
Penther D, Preudhomme C, Talmant P, Roumier C, Godon A, Mechinaud F et al. Amplification of AML1 gene is present in childhood acute lymphoblastic leukemia but not in adult, and is not associated with AML1 gene mutation. Leukemia 2002; 16: 1131–1134.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gadner, H., Haas, O., Masera, G. et al. ‘Ponte di Legno’ Working Group – Report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April – 1 May 2002. Leukemia 17, 798–803 (2003). https://doi.org/10.1038/sj.leu.2402872
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402872
This article is cited by
-
Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome
Leukemia (2008)
-
The eighth international childhood acute lymphoblastic leukemia workshop (‘Ponte di Legno meeting’) report: Vienna, Austria, April 27–28, 2005
Leukemia (2006)
-
The Seventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Palermo, Italy, January 29–30, 2005
Leukemia (2005)
-
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
Leukemia (2004)
-
Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia
Leukemia (2004)